Since the PI3K/Akt pathway is aberrantly activated in many cancers and plays a central role in tumor cell proliferation, the antiproliferative effect of digoxin in NSCLC cells might be attributed to its inhibition of the PI3K/Akt pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.